Published in Nephron on December 01, 2002
Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis. Clin Exp Immunol (2008) 0.79
Interindividual and intraindividual variations in postprandial glycemia peak time complicate precise recommendations for self-monitoring of glucose in persons with type 1 diabetes mellitus. J Diabetes Sci Technol (2012) 0.77
CCL2/CCR2 augments the production of transforming growth factor-beta1, type 1 collagen and CCL2 by human CD45-/collagen 1-positive cells under high glucose concentrations. Clin Exp Nephrol (2013) 0.75
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. N Engl J Med (2015) 4.78
Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol (2008) 4.20
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet (2003) 3.70
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10
Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis (2011) 2.88
Electrical forces determine glomerular permeability. J Am Soc Nephrol (2010) 2.74
Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther (2007) 2.58
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int (2008) 2.36
Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol (2006) 2.24
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
Diabetes and renal disease: who does what? Clin Med (2013) 2.10
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them? Nephrol Dial Transplant (2008) 2.05
CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation. J Immunol (2013) 2.03
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest (2009) 2.01
Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol (2004) 1.94
Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol (2010) 1.89
Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol Biol Cell (2007) 1.89
Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol (2007) 1.87
Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol (2009) 1.86
Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 1.85
Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 1.80
Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol (2008) 1.75
Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. Am J Kidney Dis (2011) 1.74
Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol (2005) 1.72
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol (2011) 1.66
Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol (2012) 1.63
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int (2005) 1.63
Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant (2010) 1.59
Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant (2006) 1.59
Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost (2009) 1.58
Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells. J Am Soc Nephrol (2004) 1.57
Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time? Nephrol Dial Transplant (2009) 1.53
Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits. Nephrol Dial Transplant (2005) 1.52
Prognostic impact of renal arterial resistance index upon renal allograft survival: the time point matters. Nephrol Dial Transplant (2012) 1.49
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease. Nephrol Dial Transplant (2011) 1.47
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet (2006) 1.41
Salt wars. Nephrol Dial Transplant (2008) 1.40
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One (2011) 1.39
Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol (2008) 1.38
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J Immunol (2007) 1.38
Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney Int (2013) 1.35
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol (2007) 1.34
Hyaluronan regulates transforming growth factor-beta1 receptor compartmentalization. J Biol Chem (2004) 1.33
Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol (2011) 1.29
Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J Biol Chem (2008) 1.28
Origin of regenerating tubular cells after acute kidney injury. Proc Natl Acad Sci U S A (2014) 1.27
Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol (2007) 1.26
Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol (2010) 1.21
TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol (2003) 1.21
Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol (2012) 1.20
Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. J Nephrol (2008) 1.20
Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant (2007) 1.20
Treatment targets in renal fibrosis. Nephrol Dial Transplant (2007) 1.19
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol (2007) 1.17
Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension (2006) 1.17
Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells. Am J Pathol (2004) 1.13
Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification? Kidney Int (2009) 1.13
Anemia and diabetes in the absence of nephropathy. Diabetes Care (2005) 1.13
L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes (2007) 1.11
Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. J Am Soc Nephrol (2006) 1.11
Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction. J Biol Chem (2011) 1.11
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol (2005) 1.10
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol Immunol (2007) 1.09
Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Biol (2011) 1.09
The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant (2011) 1.09
Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol (2007) 1.08
Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol (2007) 1.08
The renal (myo-)fibroblast: a heterogeneous group of cells. Nephrol Dial Transplant (2012) 1.08
The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int (2005) 1.07
PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol (2008) 1.07
In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol (2002) 1.07
Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: in vivo evidence for an immunologic danger signal. J Am Soc Nephrol (2004) 1.07
An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo. Am J Physiol Renal Physiol (2005) 1.06
Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. J Am Soc Nephrol (2003) 1.06
Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Blood Purif (2002) 1.06
Albumin is recycled from the primary urine by tubular transcytosis. J Am Soc Nephrol (2013) 1.05
The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. J Biol Chem (2011) 1.05
Primary cultures of glomerular parietal epithelial cells or podocytes with proven origin. PLoS One (2012) 1.05
Post-transcriptional regulation of Transforming Growth Factor Beta-1 by microRNA-744. PLoS One (2011) 1.05
Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem (2005) 1.04
Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol (2009) 1.04
Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest (2008) 1.03
Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int (2003) 1.03
Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol (2011) 1.03
The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol (2014) 1.02
Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Histol Histopathol (2008) 1.02
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant (2012) 1.01
Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int Suppl (2003) 1.01
Origin of parietal podocytes in atubular glomeruli mapped by lineage tracing. J Am Soc Nephrol (2013) 1.00
The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice. J Pharmacol Exp Ther (2006) 1.00
Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. Nephrol Dial Transplant (2012) 0.99
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol (2003) 0.99
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab (2013) 0.98
Subtotal ablation of parietal epithelial cells induces crescent formation. J Am Soc Nephrol (2012) 0.98